Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 47

1.

[Consensus document and recommendations for the prevention of cardiovascular disease in Italy - 2018].

Volpe M, Tocci G, Accettura D, Battistoni A, Bellone S, Bellotti P, Bertolotti M, Borghi C, Casasco M, Consoli A, Coppini R, Corsini A, Costanzo G, Desideri G, Ferri C, Galanti G, Giada F, Icardi G, Lombardi N, Modena MG, Modesti PA, Monti G, Mugelli A, Orsi A, Parati G, Pedretti RF, Perseghin G, Pirro M, Ricotti R, Rizzoni D, Rotella C, Rubattu S, Salvetti G, Sarto P, Tassinari F, Trimarco B, de Kreutzenberg SV, Volpe R.

G Ital Cardiol (Rome). 2018 Feb;19(2 Suppl 1):1S-95S. doi: 10.1714/2874.28988. Italian.

PMID:
29531376
2.

Circulating levels and characterization of microparticles in patients with different degrees of glucose tolerance.

Giannella A, Radu CM, Franco L, Campello E, Simioni P, Avogaro A, de Kreutzenberg SV, Ceolotto G.

Cardiovasc Diabetol. 2017 Sep 19;16(1):118. doi: 10.1186/s12933-017-0600-0.

3.

Hypovitaminosis D is associated with erectile dysfunction in type 2 diabetes.

Caretta N, de Kreutzenberg SV, Valente U, Guarneri G, Ferlin A, Avogaro A, Foresta C.

Endocrine. 2016 Sep;53(3):831-8. doi: 10.1007/s12020-015-0851-z. Epub 2016 Jan 12.

PMID:
26758995
4.

Metformin improves putative longevity effectors in peripheral mononuclear cells from subjects with prediabetes. A randomized controlled trial.

de Kreutzenberg SV, Ceolotto G, Cattelan A, Pagnin E, Mazzucato M, Garagnani P, Borelli V, Bacalini MG, Franceschi C, Fadini GP, Avogaro A.

Nutr Metab Cardiovasc Dis. 2015 Jul;25(7):686-93. doi: 10.1016/j.numecd.2015.03.007. Epub 2015 Mar 24.

PMID:
25921843
5.

NAD(+)-dependent SIRT1 deactivation has a key role on ischemia-reperfusion-induced apoptosis.

Cattelan A, Ceolotto G, Bova S, Albiero M, Kuppusamy M, De Martin S, Semplicini A, Fadini GP, de Kreutzenberg SV, Avogaro A.

Vascul Pharmacol. 2015 Jul;70:35-44. doi: 10.1016/j.vph.2015.02.004. Epub 2015 Apr 9.

PMID:
25863291
6.

Endothelial progenitor cells are reduced in acromegalic patients and can be restored by treatment with somatostatin analogs.

Fadini GP, Dassie F, Albiero M, Boscaro E, Albano I, Martini C, de Kreutzenberg SV, Agostini C, Avogaro A, Vettor R, Maffei P.

J Clin Endocrinol Metab. 2014 Dec;99(12):E2549-56. doi: 10.1210/jc.2014-2275.

PMID:
25144634
7.

Dipeptidyl peptidase-4 inhibitors can minimize the hypoglycaemic burden and enhance safety in elderly people with diabetes.

Avogaro A, Dardano A, de Kreutzenberg SV, Del Prato S.

Diabetes Obes Metab. 2015 Feb;17(2):107-15. doi: 10.1111/dom.12319. Epub 2014 Jun 25. Review.

PMID:
24867662
8.

Sirtuin 1 stabilization by HuR represses TNF-α- and glucose-induced E-selectin release and endothelial cell adhesiveness in vitro: relevance to human metabolic syndrome.

Ceolotto G, De Kreutzenberg SV, Cattelan A, Fabricio AS, Squarcina E, Gion M, Semplicini A, Fadini GP, Avogaro A.

Clin Sci (Lond). 2014 Oct;127(7):449-61. doi: 10.1042/CS20130439.

PMID:
24702436
9.

The endothelium abridges insulin resistance to premature aging.

Avogaro A, de Kreutzenberg SV, Federici M, Fadini GP.

J Am Heart Assoc. 2013 Jun 21;2(3):e000262. doi: 10.1161/JAHA.113.000262. Review. No abstract available.

10.

An unbalanced monocyte polarisation in peripheral blood and bone marrow of patients with type 2 diabetes has an impact on microangiopathy.

Fadini GP, de Kreutzenberg SV, Boscaro E, Albiero M, Cappellari R, Kränkel N, Landmesser U, Toniolo A, Bolego C, Cignarella A, Seeger F, Dimmeler S, Zeiher A, Agostini C, Avogaro A.

Diabetologia. 2013 Aug;56(8):1856-66. doi: 10.1007/s00125-013-2918-9. Epub 2013 Apr 26.

11.

Elevated white blood cell count is associated with prevalence and development of the metabolic syndrome and its components in the general population.

Fadini GP, Marcuzzo G, Marescotti MC, de Kreutzenberg SV, Avogaro A.

Acta Diabetol. 2012 Dec;49(6):445-51. doi: 10.1007/s00592-012-0402-5. Epub 2012 May 24.

PMID:
22623143
12.

Procalcific phenotypic drift of circulating progenitor cells in type 2 diabetes with coronary artery disease.

Fadini GP, Albiero M, Menegazzo L, Boscaro E, Agostini C, de Kreutzenberg SV, Rattazzi M, Avogaro A.

Exp Diabetes Res. 2012;2012:921685. doi: 10.1155/2012/921685. Epub 2012 Feb 28.

13.

The increased dipeptidyl peptidase-4 activity is not counteracted by optimized glucose control in type 2 diabetes, but is lower in metformin-treated patients.

Fadini GP, Albiero M, Menegazzo L, de Kreutzenberg SV, Avogaro A.

Diabetes Obes Metab. 2012 Jun;14(6):518-22. doi: 10.1111/j.1463-1326.2011.01550.x. Epub 2012 Jan 6.

PMID:
22171692
14.

Characteristics and outcomes of the hyperglycemic hyperosmolar non-ketotic syndrome in a cohort of 51 consecutive cases at a single center.

Fadini GP, de Kreutzenberg SV, Rigato M, Brocco S, Marchesan M, Tiengo A, Avogaro A.

Diabetes Res Clin Pract. 2011 Nov;94(2):172-9. doi: 10.1016/j.diabres.2011.06.018. Epub 2011 Jul 12.

PMID:
21752485
15.

The metabolic syndrome influences the response to incretin-based therapies.

Fadini GP, de Kreutzenberg SV, Gjini R, Avogaro A.

Acta Diabetol. 2011 Sep;48(3):219-25. doi: 10.1007/s00592-011-0296-7. Epub 2011 May 15.

PMID:
21574000
16.

Hemodynamics assessed via approximate entropy analysis of impedance cardiography time series: effect of metabolic syndrome.

Guerra S, Boscari F, Avogaro A, Di Camillo B, Sparacino G, de Kreutzenberg SV.

Am J Physiol Heart Circ Physiol. 2011 Aug;301(2):H592-8. doi: 10.1152/ajpheart.01195.2010. Epub 2011 May 13.

17.

Optimized glycaemic control achieved with add-on basal insulin therapy improves indexes of endothelial damage and regeneration in type 2 diabetic patients with macroangiopathy: a randomized crossover trial comparing detemir versus glargine.

Fadini GP, de Kreutzenberg SV, Mariano V, Boscaro E, Bertolini F, Mancuso P, Quarna J, Marescotti M, Agostini C, Tiengo A, Avogaro A.

Diabetes Obes Metab. 2011 Aug;13(8):718-25. doi: 10.1111/j.1463-1326.2011.01396.x.

PMID:
21410861
18.

Microangiopathy is independently associated with presence, severity and composition of carotid atherosclerosis in type 2 diabetes.

de Kreutzenberg SV, Coracina A, Volpi A, Fadini GP, Frigo AC, Guarneri G, Tiengo A, Avogaro A.

Nutr Metab Cardiovasc Dis. 2011 Apr;21(4):286-93. doi: 10.1016/j.numecd.2009.10.003. Epub 2010 Feb 16.

PMID:
20163939
19.

Downregulation of the longevity-associated protein sirtuin 1 in insulin resistance and metabolic syndrome: potential biochemical mechanisms.

de Kreutzenberg SV, Ceolotto G, Papparella I, Bortoluzzi A, Semplicini A, Dalla Man C, Cobelli C, Fadini GP, Avogaro A.

Diabetes. 2010 Apr;59(4):1006-15. doi: 10.2337/db09-1187. Epub 2010 Jan 12.

20.

Glycaemic fall after a glucose load. A population-based study.

Casiglia E, Tikhonoff V, Caffi S, Bascelli A, Guglielmi F, Mazza A, Martini B, Saugo M, D'Este D, Masiero S, Guidotti F, Boschetti G, Schiavon L, Spinella P, de Kreutzenberg SV, De Lazzari F, Pessina AC.

Nutr Metab Cardiovasc Dis. 2010 Dec;20(10):727-33. doi: 10.1016/j.numecd.2009.06.012. Epub 2009 Oct 12.

PMID:
19822409
21.

Insulin signaling and life span.

Avogaro A, de Kreutzenberg SV, Fadini GP.

Pflugers Arch. 2010 Jan;459(2):301-14. doi: 10.1007/s00424-009-0721-8. Epub 2009 Sep 13. Review.

PMID:
19756720
22.

Reduced endothelial progenitor cells and brachial artery flow-mediated dilation as evidence of endothelial dysfunction in ocular hypertension and primary open-angle glaucoma.

Fadini GP, Pagano C, Baesso I, Kotsafti O, Doro D, de Kreutzenberg SV, Avogaro A, Agostini C, Dorigo MT.

Acta Ophthalmol. 2010 Feb;88(1):135-41. doi: 10.1111/j.1755-3768.2009.01573.x. Epub 2009 Jul 22.

23.

Why to screen heart disease in diabetes.

Fadini GP, de Kreutzenberg SV, Tiengo A, Avogaro A.

Atherosclerosis. 2009 May;204(1):11-5. doi: 10.1016/j.atherosclerosis.2008.08.044. Epub 2008 Sep 27. Review.

PMID:
18977481
24.

Endothelial dysfunction: causes and consequences in patients with diabetes mellitus.

Avogaro A, de Kreutzenberg SV, Fadini G.

Diabetes Res Clin Pract. 2008 Dec 15;82 Suppl 2:S94-S101. doi: 10.1016/j.diabres.2008.09.021. Epub 2008 Oct 26. Review.

PMID:
18954919
25.

A stepwise approach to assess the impact of clustering cardiometabolic risk factors on carotid intima-media thickness: the metabolic syndrome no-more-than-additive.

Fadini GP, Coracina A, Inchiostro S, Tiengo A, Avogaro A, de Kreutzenberg SV.

Eur J Cardiovasc Prev Rehabil. 2008 Apr;15(2):190-6. doi: 10.1097/HJR.0b013e3282f17bc3.

PMID:
18391647
26.

Oxidative stress and vascular disease in diabetes: is the dichotomization of insulin signaling still valid?

Avogaro A, de Kreutzenberg SV, Fadini GP.

Free Radic Biol Med. 2008 Mar 15;44(6):1209-15. doi: 10.1016/j.freeradbiomed.2007.12.021. Epub 2008 Jan 11. Review.

PMID:
18191647
27.

Is the metabolic syndrome a cardiovascular risk factor beyond its specific components?

Inchiostro S, Fadini GP, de Kreutzenberg SV, Citroni N, Avogaro A.

J Am Coll Cardiol. 2007 Jun 26;49(25):2465; author reply 2465-6. Epub 2007 Jun 11. No abstract available.

28.

Oral 17beta-estradiol and sequential progesterone in menopause: effects on insulin-like growth factors and their binding proteins.

Mozzanega B, Babbo GL, Salmaso L, De Toni R, Schiavo A, Mioni R, de Kreutzenberg SV.

Gynecol Endocrinol. 2007 Jan;23(1):50-7.

PMID:
17484513
29.

Circulating CD34+ cells, metabolic syndrome, and cardiovascular risk.

Fadini GP, de Kreutzenberg SV, Coracina A, Baesso I, Agostini C, Tiengo A, Avogaro A.

Eur Heart J. 2006 Sep;27(18):2247-55. Epub 2006 Aug 15.

PMID:
16912055
30.

Peripheral blood CD34+KDR+ endothelial progenitor cells are determinants of subclinical atherosclerosis in a middle-aged general population.

Fadini GP, Coracina A, Baesso I, Agostini C, Tiengo A, Avogaro A, de Kreutzenberg SV.

Stroke. 2006 Sep;37(9):2277-82. Epub 2006 Jul 27.

31.

Insulin generates free radicals in human fibroblasts ex vivo by a protein kinase C-dependent mechanism, which is inhibited by pravastatin.

Ceolotto G, Papparella I, Lenzini L, Sartori M, Mazzoni M, Iori E, Franco L, Gallo A, de Kreutzenberg SV, Tiengo A, Pessina AC, Avogaro A, Semplicini A.

Free Radic Biol Med. 2006 Aug 1;41(3):473-83. Epub 2006 Apr 30.

PMID:
16843828
32.

Circulating progenitor cells are reduced in patients with severe lung disease.

Fadini GP, Schiavon M, Cantini M, Baesso I, Facco M, Miorin M, Tassinato M, de Kreutzenberg SV, Avogaro A, Agostini C.

Stem Cells. 2006 Jul;24(7):1806-13. Epub 2006 Apr 6.

33.

Effects of different insulin regimes on postprandial myocardial perfusion defects in type 2 diabetic patients.

Scognamiglio R, Negut C, de Kreutzenberg SV, Tiengo A, Avogaro A.

Diabetes Care. 2006 Jan;29(1):95-100.

PMID:
16373903
34.

Postprandial myocardial perfusion in healthy subjects and in type 2 diabetic patients.

Scognamiglio R, Negut C, De Kreutzenberg SV, Tiengo A, Avogaro A.

Circulation. 2005 Jul 12;112(2):179-84. Epub 2005 Jul 5.

35.

Mechanisms of endothelial dysfunction in obesity.

Avogaro A, de Kreutzenberg SV.

Clin Chim Acta. 2005 Oct;360(1-2):9-26. Review.

PMID:
15982646
36.

Circulating endothelial progenitor cells are reduced in peripheral vascular complications of type 2 diabetes mellitus.

Fadini GP, Miorin M, Facco M, Bonamico S, Baesso I, Grego F, Menegolo M, de Kreutzenberg SV, Tiengo A, Agostini C, Avogaro A.

J Am Coll Cardiol. 2005 May 3;45(9):1449-57.

37.

The effects of oral amino acid intake on ambulatory capacity in elderly subjects.

Scognamiglio R, Avogaro A, Negut C, Piccolotto R, de Kreutzenberg SV, Tiengo A.

Aging Clin Exp Res. 2004 Dec;16(6):443-7.

PMID:
15739594
38.

Acute alcohol consumption improves insulin action without affecting insulin secretion in type 2 diabetic subjects.

Avogaro A, Watanabe RM, Dall'Arche A, De Kreutzenberg SV, Tiengo A, Pacini G.

Diabetes Care. 2004 Jun;27(6):1369-74.

PMID:
15161790
39.

Elevated non-esterified fatty acids impair nitric oxide independent vasodilation, in humans: evidence for a role of inwardly rectifying potassium channels.

de Kreutzenberg SV, Puato M, Kiwanuka E, Del Prato S, Pauletto P, Pasini L, Tiengo A, Avogaro A.

Atherosclerosis. 2003 Jul;169(1):147-53.

PMID:
12860261
40.

L-arginine-nitric oxide kinetics in normal and type 2 diabetic subjects: a stable-labelled 15N arginine approach.

Avogaro A, Toffolo G, Kiwanuka E, de Kreutzenberg SV, Tessari P, Cobelli C.

Diabetes. 2003 Mar;52(3):795-802.

41.

Diabetic ketosis activates lymphomonocyte-inducible nitric oxide synthase.

Iori E, Calò L, Valbusa D, Ceolotto G, Milani M, Pengo V, de Kreutzenberg SV, Tiengo A, Avogaro A.

Diabet Med. 2002 Sep;19(9):777-83.

PMID:
12207816
42.

Left ventricular mass in type 2 diabetes mellitus. A study employing a simple ECG index: the Cornell voltage.

de Kreutzenberg SV, Avogaro A, Tiengo A, Del Prato S.

J Endocrinol Invest. 2000 Mar;23(3):139-44.

PMID:
10803469
43.

Plasma free fatty acids and endothelium-dependent vasodilation: effect of chain-length and cyclooxygenase inhibition.

de Kreutzenberg SV, Crepaldi C, Marchetto S, Calò L, Tiengo A, Del Prato S, Avogaro A.

J Clin Endocrinol Metab. 2000 Feb;85(2):793-8.

PMID:
10690892
44.

Gliclazide potentiates suppression of hepatic glucose production in non-insulin-dependent diabetic patients.

Riccio A, Lisato G, de Kreutzenberg SV, Marchetto S, Turrin M, Tiengo A, Del Prato S.

Metabolism. 1996 Oct;45(10):1196-202.

PMID:
8843172
45.

Effects of insulin on whole body and forearm leucine and KIC metabolism in type 1 diabetes.

Tessari P, Biolo G, Inchiostro S, Saccà L, Nosadini R, Boscarato MT, Trevisan R, De Kreutzenberg SV, Tiengo A.

Am J Physiol. 1990 Jul;259(1 Pt 1):E96-103.

PMID:
2196823
46.

Dose-response curves of effects of insulin on leucine kinetics in humans.

Tessari P, Trevisan R, Inchiostro S, Biolo G, Nosadini R, De Kreutzenberg SV, Duner E, Tiengo A, Crepaldi G.

Am J Physiol. 1986 Sep;251(3 Pt 1):E334-42.

PMID:
3529984
47.

Defective suppression by insulin of leucine-carbon appearance and oxidation in type 1, insulin-dependent diabetes mellitus. Evidence for insulin resistance involving glucose and amino acid metabolism.

Tessari P, Nosadini R, Trevisan R, De Kreutzenberg SV, Inchiostro S, Duner E, Biolo G, Marescotti MC, Tiengo A, Crepaldi G.

J Clin Invest. 1986 Jun;77(6):1797-804.

Supplemental Content

Loading ...
Support Center